Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

U.S. Senator Bernie Sanders said on Tuesday he had commitments from the nation's top pharmacy benefit managers that they ...

BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...

Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Patients on semaglutide, the active ingredient in Ozempic and the weight-loss drug Wegovy, were less than half as likely to ...

Researchers have identified a potential new approach to address the opioid overdose epidemic. Semaglutide was shown to lower opioid overdoses in people with opioid-use disorder and type 2 diabetes.

WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a ...